The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
411 AERONIDE 200 MCG EACH ACTUATION CONTAINS: BUDESONIDE 200 MCG SUSPENSION FOR INHALATION CANISTER PREVENT SYMPTOMS OF ASTHMA NULL DKSH LAOS COMPANY LIMITED INPAC PHARMA CO.,LTD THAILAND CERTIFICATE RELEASED 08 I 5282/22 26-AUG-2022 25-AUG-2025 View
412 AEROTAMOL 100 MCG EACH ACTUATION CONTAINS: SALBUTAMOL SULPHATE 0.1205 MG EQ.TO SALBUTAMOL 0.1 MG SUSPENSION FOR INHALATION CANISTER FOR THE RELIEF AND PREVENTION OF ASTHMA SYMPTOMS IN MILD, MODERATE OR SEVERE ASTHMA. IT SHOULD BE USED TO RELIEVE SYMPTOMS WHEN THEY OCCUR, AND TO PREVENT THEM IN THOSE CIRCUMSTANCE RECOGNISED BY THE PATIENTS TO PRECIPIATE AS ASTHMA ATTACK (E.G. BEFORE EXERCISE OR ANAVOIDABLE ALLERGEN EXPOSURE) NULL DKSH LAOS COMPANY LIMITED INPAC PHARMA CO.,LTD THAILAND CERTIFICATE RELEASED 08 I 5283/22 26-AUG-2022 25-AUG-2025 View
413 AKYNZEO PALONOSETRON HYDROCHLORIDE EQ.TO PALONOSETRON 0.5 MG, NETUPITANT 300 MG CAPSULE ALU-BLISTER PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH HIGHLY EMETOGENIC CISPLATIN BASED CANCER CHEMOTHERAPY, PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITIN ASSOCIATED WITH MODERATELY EMETOGENIC CANCER CHEMOTHERAPY NULL DKSH LAOS COMPANY LIMITED HELSINN BIREX PHARMACEUTICALS LTD IRELAND CERTIFICATE RELEASED 04 I 5474/23 25-APR-2023 24-APR-2026 View
414 ALDACTONE SPIRONOLACTONE 25 MG TABLET ALU-STRIP ESSENTIAL HYPERTENSION, SHORT-TERM PREOPERATIVE TREATMENT OF PATIENTS WITH PRIMARY HYPERALDOSTERONISM, DIURETIC-INDUCED HYPOKALEMIA/HYPOMAGNESEMIA AS ADJUNCTIVE THERAPY, MANAGEMENT OF HIRSUTISM. NULL DKSH LAOS COMPANY LIMITED OLIC (THAILAND) LIMITED THAILAND CERTIFICATE RELEASED 11 I 3991/13 22-JUN-2024 21-JUN-2027 View
415 ALEVE 220 MG NAPROXEN SODIUM 220 MG FILM-COATED TABLETS BLISTERPACK RELIEF FOR THE TEMPORARY MANAGEMENT OF THE PAIN AND DISCOMFORT ASSOCIATED WITH HEADACHE, BACKACHE,MASCULAR ACHE AND PAIN, TOOTHACHE, PERIOD PAIN,MINOR PAIN OF ARTHRITIS, REDUCE FEVER SUCH AS THAT ASSOCIATED WITH THE COMMON COLD NULL DKSH LAOS COMPANY LIMITED BAYER BITTERFELD GMBH GERMANY CERTIFICATE RELEASED 04 I 4414/18 14-SEP-2022 13-SEP-2025 View
416 ALOXI 50 MCG/ML PALONOSETRON (AS HYDROCHLORIDE) 250 MCG/5ML SOLUTION FOR INJECTION VIAL PREVENTION OF ACUTE NAUSEA, NAUSEA AND VOMITING ASSOCIATED WITH MODERATELY AND HIGHLY EMETOGENIC CANCER CHEMOTHERAPY IN ADULTS AND PAEDIATRIC PATIENTS 1 MONTH OF AGE AND OLDER. NULL DKSH LAOS COMPANY LIMITED FAREVA PAU 1 FRANCE CERTIFICATE RELEASED 06 I 4504/18 07-APR-2025 06-APR-2030 View
417 ALOXI 75 MCG/1.5 ML PALONOSETRON (AS HYDROCHLORIDE) 75 MCG/1.5 ML SOLUTION FOR INJECTION VIAL PREVENTION OF ACUTE NAUSEA AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES IN MODERATELY EMETOGENIC CANCER CHEMOTHERAPY. NULL DKSH LAOS COMPANY LIMITED FAREVA PAU 1 USA CERTIFICATE RELEASED 06 I 4505/18 07-APR-2025 06-APR-2030 View
418 AMLOWAN 10 AMLODIPINE BESYLATE USP EQ.TO AMLODIPINE 10 MG TABLET ALU-ALU BLISTER PACK HYPERTENSION, CHRONIC STABLE ANGINA PECTORIS, VASOSPASTIC (PRINZMETAL'S) ANGINA NULL DKSH LAOS COMPANY LIMITED ARGON REMEDIES PVT.LTD INDIA CERTIFICATE RELEASED 01 I 5661/24 26-JAN-2024 25-JAN-2027 View
419 AMLOWAN 5 AMLODIPINE BESYLATE USP EQ.TO AMLODIPINE 5 MG TABLET ALU-ALU BLISTER PACK HYPERTENSION, CHRONIC STABLE ANGINA PECTORIS, VASOSPASTIC (PRINZMETAL'S) ANGINA NULL DKSH LAOS COMPANY LIMITED ARGON REMEDIES PVT.LTD INDIA CERTIFICATE RELEASED 01 I 5662/24 26-JAN-2024 25-JAN-2027 View
420 ANTIPLATT CLOPIDOGREL BISULFATE USP EQ.TO CLOPIDOGREL 75 MG FILM COATED TABLET ALU-ALU BLISTER FOR THE REDUCTION OF ATHEROTHROMBOTIC EVENTS AS FOLLOWS: RECENT MI, RECENT STROKE OR ESTABLISHED PERIPHERAL ARTERIAL DISEASE FOR PATIENTS WITH A HISTORY OF RECENT MYOCARDIAL INFARCTION, RECENT STROKE, ESTABLISHED PERIPHERAL ARTERIAL DISEASE. FOR PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION NULL DKSH LAOS COMPANY LIMITED TROIKAA PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 05 I 5092/21 08-APR-2024 07-APR-2027 View